Open AccessTreatment of localized scleroderma with hyaluronidase
Author(s) -
А. С. Дворников
Publication year - 2013
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv627
Subject(s) - scleroderma (fungus) , medicine , hyaluronidase , dermatology , localized scleroderma , disease , pathology , enzyme , biochemistry , chemistry , lichen sclerosus , inoculation
Goal. To evaluate the efficacy of treatment of patients suffering from localized scleroderma with Longidaza. Materials and methods. The study sample included 300 patients with localized scleroderma (158 with the plaque form and 142 with white spot disease) treated with Longidaza in 2002—2010. Results. Complex therapy of patients suffering from localized scleroderma with Longidaza proved to be efficient in 71.3% of the patients. Conclusion. These results confirm that inclusion of the Russian enzymatic drug Longidaza into the complex treatment of patients suffering from the aforesaid pathology seems to be expedient.